Acelyrin Market Cap

Acelyrin has a market cap or net worth of $447.76 million as of April 23, 2024.

Market Cap

447.76M

Enterprise Value

-260.20M

1-Year Change

n/a

Ranking

#2987

Market Cap Chart

Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $447.76M, a decrease of -73.17%. That is a compound annual growth rate of -74.34%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	474.10M	-3.79%
Apr 19, 2024	492.80M	2.67%
Apr 18, 2024	480.00M	-2.79%
Apr 17, 2024	493.80M	-2.33%
Apr 16, 2024	505.60M	-6.89%
Apr 15, 2024	543.00M	2.80%
Apr 12, 2024	528.20M	-6.78%
Apr 11, 2024	566.60M	1.05%
Apr 10, 2024	560.70M	-4.20%
Apr 9, 2024	585.30M	-1.65%
Apr 8, 2024	595.10M	-0.33%
Apr 5, 2024	597.10M	-5.01%
Apr 4, 2024	628.60M	-3.62%
Apr 3, 2024	652.20M	1.38%
Apr 2, 2024	643.30M	-1.80%
Apr 1, 2024	655.10M	-1.34%
Mar 28, 2024	664.00M	1.07%
Mar 27, 2024	657.00M	1.50%
Mar 26, 2024	647.30M	-1.34%
Mar 25, 2024	656.10M	-2.67%
Mar 22, 2024	674.10M	-10.99%
Mar 21, 2024	757.30M	-6.49%
Mar 20, 2024	809.90M	4.53%
Mar 19, 2024	774.80M	4.46%
Mar 18, 2024	741.70M	-2.80%

View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nano-X Imaging	492.72M
Arbutus Biopharma	490.08M
Orthofix Medical	490.03M
Altimmune	489.89M
KalVista Pharmaceuticals	488.12M
Alector	487.36M
Annexon	479.19M
Third Harmonic Bio	475.54M

Market Cap Rankings